IFT - Infratil

[Left Field]

Lower end of EBITDAF guidance from CDC for FY 2026, but upgrade for FY2027 it seems....

https://www.nzx.com/announcements/469924

Infratil had previously guided that CDC's FY25 EBITDAF would double to approximately A$660 million in FY27. Higher formal FY27 EBITDAF guidance of A$680 million to $720 million is now provided based on the updated outlook for delivery of existing contracted capacity and the expectation for continued strong demand.
 
 FY26 EBITDAF is expected to be at the lower end of the current guidance range of A$390 million to A$400 million, reflecting the timing of existing contracted capacity that has been weighted toward the back end of FY26.

Full CDC investor update here;

https://api.nzx.com/public/announcement/469924/attachment/465353/469924-465353.pdf

[Swala]

Market seems to like it.

[Swala]

Good week for Infratil, up 10%

[mike2023]

I thought IFT would be a fairly safe bet in the current environment. Energy and data seem like good options.

[Left Field]

Onwards and upwards....... IFT proving to be a good defensive stock

https://www.nzx.com/announcements/470527

CDC's valuation increased by 7.2% during the quarter, reflecting continued growth in CDC's pipeline of operating and planned capacity, and the successful completion of a A$500 million equity raise (with Infratil contributing A$250 million) to support acceleration of the development pipeline.
 
 Excluding the equity raise, the valuation increased by 3.5% on a like‑for‑like basis.
 
 The 31 March 2026 independent valuation of CDC increased by A$1.0 billion from 31 December 2025, to A$15.0 billion, reflecting the mid-point of the assessed valuation range of A$14.1 billion to A$16.0 billion.
 
 On this basis, Infratil's 49.72% interest in CDC is valued at A$7,454 million, up A$500 million from A$6,954 million at 31 December 2025.

[Left Field]

On the other channel Kiora has posed a question to Ai asking which of IFT or Berkshire Hathaway has been the best investment since IFT's listing in 1994.

Here's Ai's answer as posted by Kiora.

Yes, over the past 30 years (since its listing in 1994), Infratil has generally been a better performing investment than Berkshire Hathaway in terms of annualised returns.

www.intelligentinvestor.com.auwww.intelligentinvestor.com.au
Infratil (IFT): Has delivered an average annual return to shareholders of approximately 18.7% to 19% over the 30-year period ending in 2024.

Berkshire Hathaway (BRK): Warren Buffett's investment vehicle has returned about 13% per year over the same period, according to an analysis.

www.intelligentinvestor.com.auwww.intelligentinvestor.com.au +1

While Berkshire Hathaway is widely considered one of the best long-term investments in history over a 50+ year timeframe, Infratil's focused infrastructure strategy has delivered higher annualised returns over the last three decades.

Key Findings:

Extraordinary Growth: A $1,000 investment in Infratil's 1994 initial public offering (IPO) would have grown to over $200,000 by late 2025.

Recent Performance: Infratil's strong performance has been boosted in recent years by its focus on data centres, renewable energy, and digital infrastructure (such as CDC Data Centres and One NZ).

Total Shareholder Return: Infratil's Total Shareholder Return (TSR), which includes dividends and reinvestment, was particularly strong, showing over 190% over a recent 5-year period.

Both companies are lauded for their longevity and management, but Infratil's specific focus on infrastructure asset management has allowed it to outperform Berkshire's more diversified conglomerate model over this specific 30-year timeframe.